Evommune

EVMN · NYSE

$5.38+$0.11 (+2.09%)TodayMarket closed ·
Prev close $5.27

Who owns EVMN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 69.6% of EVMN’s shares.

  • EQT Partners AB14.7%
  • EQT Life Sciences13.7%
  • RA Capital Management, LP9.7%
  • Pivotal Bioventure Partners Investment Advisor LLC5.3%
  • Next 6 largest institutions26.2%
  • All other shareholders30.4%
Top institutional holders of EVMN
HolderShares% of shares
EQT Partners AB5.29M14.68%
EQT Life Sciences4.93M13.69%
RA Capital Management, LP3.49M9.70%
Pivotal Bioventure Partners Investment Advisor LLC1.93M5.35%
T. Rowe Price Associates, Inc.1.92M5.33%
Point72 Asset Management, L.P.1.91M5.30%
RTW Investments L.P.1.50M4.17%
Nan Fung Life Sciences1.44M4.00%
Andera Partners S.A.S.1.39M3.86%
SymBiosis Capital Management, LLC1.28M3.56%

Largest mutual fund holders

Top mutual fund holders of EVMN
HolderShares% of shares
Eventide Healthcare & Life Sciences Fund940.12K2.61%
Vanguard Total Stock Market Index Fund739.07K2.05%
T. Rowe Price New Horizons Fund614.72K1.71%
American Century Small Cap Growth Fund567.83K1.58%
iShares Russell 2000 ETF330.67K0.92%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $146.26K (2 trades) and sold $2.28M (9 trades) of EVMN on the open market.

Latest EVMN insider transactions
InsiderTypeSharesValue
Pena Luis C.Award1.11K$7.83K
Carver KyleBuy1.00K$13.26K
KIRSCH ARTHUR SBuy10.00K$133.00K
Patel Jeegar PravinkumarOption exercise1.49K—
Patel Jeegar PravinkumarSale1.49K$33.48K
Patel Jeegar PravinkumarOption exercise1.49K$5.71K
Drew Janice SuzannOption exercise16.16K—
Drew Janice SuzannOption exercise3.84K—
Drew Janice SuzannSale20.00K$452.60K
Drew Janice SuzannOption exercise16.16K$48.32K

Short interest

Settled Sep 30, 2026

Shares short
2.89M
Days to cover
3.86
% of shares outstanding
8.03%
Average daily volume
749.52K
Change since last report
+0.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.